CID 135923018

Chembl478019

Structural Information

Molecular Formula
C21H28N6O7S2
SMILES
CC(C)CCN1C(=O)C(=C(C(=N1)N2CCOCC2)O)C3=NS(=O)(=O)C4=C(N3)C=CC(=C4)NS(=O)(=O)C
InChI
InChI=1S/C21H28N6O7S2/c1-13(2)6-7-27-21(29)17(18(28)20(23-27)26-8-10-34-11-9-26)19-22-15-5-4-14(24-35(3,30)31)12-16(15)36(32,33)25-19/h4-5,12-13,24,28H,6-11H2,1-3H3,(H,22,25)
InChIKey
CSQSOLBGPHWFDY-UHFFFAOYSA-N
Compound name
N-[3-[5-hydroxy-2-(3-methylbutyl)-6-morpholin-4-yl-3-oxopyridazin-4-yl]-1,1-dioxo-4H-1lambda6,2,4-benzothiadiazin-7-yl]methanesulfonamide
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

1
References

1
Patents

540.1461 Da
Monoisotopic Mass

-0.1
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 541.15338 218.4
[M+Na]+ 563.13532 224.6
[M-H]- 539.13882 219.3
[M+NH4]+ 558.17992 217.0
[M+K]+ 579.10926 218.9
[M+H-H2O]+ 523.14336 209.8
[M+HCOO]- 585.14430 216.2
[M+CH3COO]- 599.15995 242.6
[M+Na-2H]- 561.12077 221.8
[M]+ 540.14555 220.6
[M]- 540.14665 220.6
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe